In the Netherlands, approximately 1 out of 8 women is diagnosed with breast cancer. This diagnosis has a major impact on someone’s life. The treatment of breast cancer often involves chemotherapy, which has the potential side effect of changing the body composition. These changes in body composition may cause health risks, which is why the COBRA study focuses on this topic.
COBRA stands for Change Of Body composition in BReast cancer: All-in assessment. The research team investigates possible changes in adipose tissue and muscular tissue during chemotherapy.
The COBRA study is conducted by Wageningen University and VU University Amsterdam in cooperation with several hospitals throughout the Netherlands and is financed by the Dutch Cancer Society (KWF Kankerbestrijding) and Alpe d’HuZes.